ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 740645 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 740645; 2) Community: the network communities that were significantly associated with the response to NSC 740645; 3) Molecule: the relationships between components within communities and NSC 740645; 4) MDR: the compounds that were significantly associated with the NSC 740645.

NSC Compound Enrichment Correlation
NSC 40273 Null 0.00286159651545682 0.26079987
NSC 606985 Camptothecin Derivative 0.00286159651545682 0.79650783
NSC 616348 Irinotecan hydrochloride 0.00286159651545682 0.78069191
NSC 617581 Null 0.00286159651545682 0.38178802
NSC 646127 6H-Pyrido[4,3-b]carbazole, 1,2-dihydro-2,5,9,11-tetra- methyl- 0.00286159651545682 0.069846408
NSC 668476 Null 0.00286159651545682 0.19950842
NSC 678925 1-Phenazinecarboxamide, N-[2-(dimethylamino)ethyl]- 9-fluoro-, monohydrochloride 0.00286159651545682 0.4351638
NSC 681645 Camptothecin Derivative 0.00286159651545682 0.82519253
NSC 682011 Benzimidazo[1,2-b]isoquinoline-6-carbonitrile, 7,8,9,10-tetrahydro-11-[(4-fluorophenyl)amino]- 0.00286159651545682 0.35062809
NSC 710340 6H,7H-[1]Benzopyrano[4,3-b][1]benzopyran-7-one,3,8,10-tri hydroxy-9,11-bis(3-methyl-2-butenyl)-6-(2-methyl-1-propenyl)- (9CI) 0.00286159651545682 0.40323759
Total:110  Current:16    [First] [Prev] [Next] [Last]